e/Zostavax

Information
has gloss	eng: Zostavax is a live vaccine developed by Merck & Co. which has been shown to reduce the incidence of herpes zoster (known as shingles) by 51.3% in a study of 38,000 adults aged 60 and older who received the vaccine. The vaccine also reduced by 66.5% the number of cases of postherpetic neuralgia and reduced the severity and duration of pain and discomfort associated with shingles, by 61.1%. Local reactions at the injections site were generally mild.
lexicalization	eng: Zostavax
instance of	(noun) immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies vaccinum, vaccine